FIELD: medicine.
SUBSTANCE: disclosed are artificial sputum analogues (versions) for simulating the states of respiratory obstruction in animals in vivo and chemical-biological laboratory studies in vitro, which are aqueous solutions, containing the following ingredients per 100 ml of the solution in a wt.% ratio: sodium alginate 0.5 or sodium alginate from 0.5 to 1.5; potato starch 2.0 or potato starch 0; edible gelatine 1.0 or bovine serum albumin from 0.2 to 1.0; chemically pure sodium chloride 0.9 or chemically pure sodium chloride 0.5 to 0.9; distilled water—balance; wherein sodium hydroxide is added in an effective amount to ensure the acidity level of the solution with pH from 5.6 to 8.2.
EFFECT: group of inventions provides producing an artificial sputum analogue close in physical and chemical properties to natural sputum, suitable for modeling biofeedback in vivo, as well as for conducting experiments with sputum in vitro.
4 cl, 2 dwg, 3 tbl, 12 ex
Title | Year | Author | Number |
---|---|---|---|
ARTIFICIAL SPUTUM FOR MODELING RESPIRATORY OBSTRUCTION IN COVID-19 | 2021 |
|
RU2748999C1 |
WARM ALKALINE SOLUTION OF HYDROGEN PEROXIDE FOR INTRAPULMONARY INJECTION | 2023 |
|
RU2807851C1 |
WAY OF MODELLING OF CHRONIC OBSTRUCTIVE DISEASE OF LUNGS | 2008 |
|
RU2360296C1 |
METHOD OF TREATMENT AND PREVENTION OF RECURRENT BRONCHITIS ASSOCIATED WITH IMPACT OF FINE DUST IN CHILDREN | 2018 |
|
RU2682116C1 |
METHOD FOR EARLY DIAGNOSIS OF BRONCHITIS IN CALVES | 2015 |
|
RU2599377C1 |
METHOD OF TREATING BRONCHIAL TUBERCULOSIS IN PATIENTS WITH LUNG TUBERCULOSIS WITH A MULTIDRUG RESISTANCE / EXTENSIVELY DRUG RESISTANCE OF DISEASE CAUSATIVE AGENT | 2019 |
|
RU2727760C1 |
METHOD OF INDUCED SPUTUM SAMPLING IN CHILDREN TO ESTIMATE SEVERITY AND NATURE OF BRONCHIAL MUCOSA INFLAMMATION | 2008 |
|
RU2364341C1 |
METHOD FOR ASSESSING THE RISK OF SIDE EFFECTS FROM THE USE OF MUCOLYTICS IN RESPIRATORY DISEASES OF BOVINE ANIMALS | 2018 |
|
RU2706601C1 |
AEROSOL FOR INHALATIONS OF GLUTOVENT PHARMACEUTICAL COMPOSITION AND METHOD FOR ITS USING IN THERAPY | 2001 |
|
RU2190422C1 |
METHOD OF TREATMENT OF PATIENTS WITH BRONCHOPULMONARY PATHOLOGY | 1993 |
|
RU2073516C1 |
Authors
Dates
2024-07-22—Published
2023-12-06—Filed